Regulus Therapeutics Inc. (NASDAQ:RGLS) Q3 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Regulus Therapeutics Inc. Q3 2022 Earnings Conference Call. . I would now like to turn the conference over to Chief Financial Officer, Cris Calsada.